Tag: Pulmonary embolism
New analysis details learning curve effect behind ‘significant improvement’ in performance...
A multisite hospital system analysis of the safety and procedural learning curve behind the performance of percutaneous mechanical thrombectomy for pulmonary embolism (PE) shows...
Akura Medical enrols first patient in QUADRA-PE study
Akura Medical has announced today the first patient enrolment in the QUADRA-PE study evaluating the Katana thrombectomy system in patients with acute pulmonary embolism...
New analysis shows patients treated with Penumbra’s CAVT technology for PE...
Penumbra has announced new data that demonstrate patients with intermediate-risk pulmonary embolism (PE) treated with Penumbra's computer-assisted vacuum thrombectomy (CAVT) technology have a shorter...
TCT 2024: PEERLESS trial finds large-bore mechanical thrombectomy superior for intermediate-risk...
Findings from the first international randomised controlled trial (RCT) to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT)...
Thrombolex begins enrolment in RAPID-PE study of Bashir catheter
Thrombolex has announced the enrolment of the first two patients in the RAPID-PE study using the Bashir endovascular catheter for the treatment of acute...
Inari Medical updates ClotTriever XL IFU amid FDA recall notice
The Food and Drug Administration (FDA) has issued a Class I recall—the most serious type—for Inari Medical's ClotTriever XL, 30mm device due to reports...
Thrombolex and Aidoc announce strategic partnership to advance breakthrough PE treatment
Thrombolex and Aidoc have announced a strategic partnership aimed at revolutionising the treatment of acute pulmonary embolism (PE), a press release reports.
This strategic collaboration,...
Unmet needs and paradigm shifts: VESS scientific sessions set to plumb...
Selected research to be presented during the Wednesday afternoon, June 19, series of Vascular and Endovascular Surgery Society (VESS) Scientific Sessions (from 1:30 p.m....
Tackling inequities in venous care
During the 2024 American Venous Forum (AVF;March 3–6) in Tampa, Florida, multiple presenters discussed inequities in venous care with a focus on how to...
Penumbra announces FDA clearance of Lightning Flash 2 for the treatment...
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Flash 2, the next generation computer assisted vacuum thrombectomy (CAVT)...
FlowTriever device found to dramatically improve breathing among intermediate-risk acute pulmonary...
SCVS 2024 saw Zachary AbuRahma, DO, an assistant professor of vascular surgery at West Virginia University and the Charleston Area Medical Center in Charleston,...
Adoption of AI into workflow associated with faster time to assessment...
An abstract presented at the 2024 American Venous Forum (AVF) annual meeting (March 3–6) revealed that, in the treatment of patients with pulmonary embolism...
Large administrative databases enter crosshairs as comparative analysis shows percutaneous mechanical...
The pitfalls of large administrative databases came to the fore during the presentation of a propensity-match scoring analysis demonstrating that percutaneous mechanical thrombectomy (MT)...
Enrollment complete in APEX-AV study of mechanical aspiration system for acute...
Patient enrollment is now complete in the APEX-AV trial evaluating the safety and efficacy of the AlphaVac F1885 (AngioDynamics) multipurpose mechanical aspiration system for...
The top 10 most popular Vascular Specialist stories of November 2023
In November, the most read stories from Vascular Specialist include a reassessment of which carotid revascularization treatment modality is best after the recent Centers...
The pulmonary arterial tree—it is time we branch out
Nicolas Mouawad, MD, chief of vascular surgery at McLaren Health System in Bay City, Michigan, urges vascular surgeons to “get out of their comfort...
Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid,...
Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs)...
Akura thrombectomy system for PE appears safe and demonstrates reduction of...
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system...
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...
Thrombolex announces new insights from the RESCUE trial with the Bashir...
Thrombolex has announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of...
NESVS 2023: Novel IVC filter retrieval device slashes procedural time and...
An inferior vena cava (IVC) filter retrieval device dubbed the next-generation in removal of the venous thromboembolism-fighting tools could substantially cut procedural times and...
New clinical data support AI solution for improved PE detection and...
Viz.ai has announced new clinical data supporting advancements in pulmonary embolism (PE) detection. Two studies have demonstrated the real-world clinical efficacy of Viz.ai’s PE module to...
‘Vascular surgery should be a key member of pulmonary embolism response...
“PERT care is the coalition of the willing,” quipped Dennis Gable, MD, a vascular surgeon at Texas Vascular Associates in Plano, Texas. He was...
The essential ‘need’ for vascular surgeons in pulmonary embolism treatment paradigm
The specter of pulmonary embolism (PE) as a common and lethal disease process—with mortality of massive PE static at about 50% for decades while...
FLAME, FLASH and ongoing PEERLESS trials collect ‘compelling’ data for FlowTriever...
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism...
The top 10 most popular Vascular Specialist stories of February 2023
In February 2023, the hits with Vascular Specialist readers included positive safety and efficacy findings from the PRESERVE trial; the announcement of the scientific program...
AVF 2023: FLASH registry suggests ‘favorable safety and effectiveness profile’ in...
Among 61 high-risk pulmonary embolism (PE) patients followed through to the 30-day visit in the U.S. cohort of the FLASH registry, no mortalities were...
New study demonstrates IVC filters ‘safe and effective’ in treating venous...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
Viz.ai launches AI-powered Viz Vascular Suite
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligence (AI)-powered software enabling vascular care teams to automatically detect and triage care for suspected pulmonary...
Penumbra launches Lightning Flash mechanical thrombectomy system
Penumbra have announced the Food and Drug Administration (FDA) clearance and launch of its Lightning Flash mechanical thrombectomy system.
“Lightning Flash features Penumbra’s novel Lightning intelligent...
FLASH results demonstrate ‘excellent safety profile’ of the FlowTriever system in...
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 real-world patients.
This is according to Catalin...
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...
CLTI, VTE and post-thrombotic syndrome: Leading experts discuss crucial decision-making in...
This advertorial is sponsored by ACHL.
For Anahita Dua, MBChB, the stark realities and complexities of peripheral arterial disease (PAD) patients undergoing endovascular treatment for...
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomized controlled trial (RCT) comparing the outcomes of patients with...
Thrombolex: Investigational RESCUE trial yields ‘exciting’ interim data
The prespecified interim analysis of the first 62 evaluable pulmonary embolism (PE) patients enrolled in the investigational RESCUE trial produced positive results, Thrombolex has...
‘Leveraging multiple teams and cardiovascular specialists’
This quarter’s Leadership Corner features Young Erben, MD, interviewing Charles B. Ross, MD, chief of vascular and endovascular services at Piedmont Heart Institute, Piedmont...
Viz.ai reveals launch of new AI-powered modules for pulmonary embolism, aortic...
Viz.ai—a company focused on artificial intelligence (AI)-driven intelligent care coordination—today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism (PE) and...
AI triage solution for PE and aortic dissection receives FDA clearance
Medical imaging artificial intelligence (AI) specialist, Avicenna.AI, recently announced that it has received certification in the U.S. and European Union (EU) for CINA CHEST, its...
First pulmonary embolism patient enrolled in FLAME study
Inari Medical has announced the enrollment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study....
Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness
AMELIA ISLAND, Fla.—As a podium talk at the annual meeting of the American Venous Forum (AVF), it represented a bit of an outlier. It...